BridgeMD
Compares treatment options for Subclavian Vein Stenosis
Official title Central Vein Stenosis Due to Dialysis Catheter Insertion in Subclavian Compared to Jugular Vein
ClinicalTrials.gov ID: NCT04871568
What this study is testing
- What it's testing
- Central vein stenosis (CVS) is a well-known complication of central venous catheterization, especially after insertion of temporary hemodialysis catheters (tHDC). Incidence and prevalence differ between studies, and exact figures are hard to tell since proper venographies seldom are performed unless the patient is symptomatic.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (18 years of age or older).
- In need of a tCDC with an expected treatment time of at least 7 days.
- Informed consent.
You likely can't join if
- Intravenous pacemaker or a PICC-line via right-sided central veins in situ.
- Known right-sided CVS.
- AV fistula on the right upper extremity.
- History of central venous vascular interventions including stents, dilatations and more (but not previous central venous catheterization).
- Central venous catheter in the right internal jugular vein or in the right subclavian vein in situ.
- Either the right jugular vein or the right subclavian vein unavailable for catheterization due to, e.g., local skin infection, thrombosis or...
See the full eligibility criteria
- Adults (18 years of age or older).
- In need of a tCDC with an expected treatment time of at least 7 days.
- Informed consent.
- Intravenous pacemaker or a PICC-line via right-sided central veins in situ.
- Known right-sided CVS.
- AV fistula on the right upper extremity.
- History of central venous vascular interventions including stents, dilatations and more (but not previous central venous catheterization).
- Central venous catheter in the right internal jugular vein or in the right subclavian vein in situ.
- Either the right jugular vein or the right subclavian vein unavailable for catheterization due to, e.g., local skin infection, thrombosis or inability to visualize the vein with ultrasound.
- Known allergy to iodinated contrast agents.
- BMI \>35 kg/m2.
- No study physician available for the catheterization.
The study team makes the final eligibility decision.
Where it's taking place
- Lund, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lund, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.